feedthegoat27
Well-Known Member
- Joined
- 12 May 2011
- Messages
- 2,047
Very interesting but a claim in Europe where the punishment is based on a financial fine is one thing. There is no chance that in the USA where 'punative' damages can be awarded that such a get out of jail card would be offered.I am no expert, and I certainly don't claim to be. I'm also pretty sure that the majority on here are only getting info from media / internet, which is what I have done. Who knows if what we read is fake news or not. People can make up their own mind about what is right for them, if you want to get the vaccine and feel it is right for you then great I hope it works out well for you. But for people to come on here and say someone's opinion is wrong when they don't have the expertise to back it up what they are saying and then just revert to swearing at people is very narrow minded in my opinion.
With regards to liability take a look at this
https://uk.reuters.com/article/uk-h...ield-against-side-effect-claims-idUKKCN26D0UG
You know more than the experts then, you are not immune for a yearNo because I had Covid in early November and therefore have immunity for at least 12 months. Will probably have it next Autumn by which time we should know more about possible side effects
Interesting post, ta mate.My concern is safety, obviously. This is my area of expertise, not virology per se but drug/vaccine development as a physician/clinician/researcher. There's a reason why we have these development standards, when you rush through them you have to go in knowing you are taking risks. It's precisely why I proposed that they should prioritize highest risk groups first while continuing to work.
Imagine if in 12 months we're no better positioned if not worse and everyone put all their eggs in this vaccine basket. Ordinarily I would say that is unlikely since in all probability parallel activities will continue to better understand COVID as well as treatment/vaccine possibilities. However, I have also seen governments around the globe failing to do the obvious thus far and opting for risk mitigation scenarios at the expense of lives
So I am cautious, not cynical - just we need to appreciate this isn't a miracle that some are certain of
Does that make any difference to the vaccine being ready to go, he is one man versus thousands who are working on a vaccineI stand corrected.
It's actually Patrick Vallance, Scientific Advisor to the Government, that has shares on GSK
https://www.google.com/amp/s/www.te...-has-600000-shareholding-firm-contracted/amp/
No conflict of interest there then...
Sorry, but this is simply incorrect. You can read the peer reviewed phase I/II results here.
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults - Nature
In a dose-escalation study of the COVID-19 RNA vaccine BNT162b1 in 45 healthy adults, RBD-binding IgG concentrations and SARS-CoV-2 neutralizing titres in sera increased with dose level and after a second vaccine dose.www.nature.com
Agree - yet you claimed, in direct contradiction, they demonstrated effectiveness at... ..the base strain... ...effectiveness changes depending on stage & strain. You're not being at all consistent here.
On other points - peer review publication is not part of any regulatory processes. Though I agree it should proceed as fast as possible here, and I'm sure it will.
Benefits here are evidently not mere hopes - efficacy has been shown to a level of benefit way above what would be the baseline requirement for approval, and way above any measure of statistical significance.
Your position would be valid if benefits were low - if this were a chickenpox vaccine perhaps. But the benefits are very, very high with over 0.1% of the UK population already dead despite unprecedented measures to suppress the virus.
You know more than the experts then, you are not immune for a year
Phase I & II trials do not involve placebo, that's why they refer to it as combined I/II - it is a rushed attempted to look at safety & treatment effect/dose. It is not the standard approach to evaluating safety profile or dose response to treatment
Effectiveness with the base strain does not translate to effectiveness with any strain of COVID - just one version
You want to shift the narrative